- Home
- / Momenta Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Momenta Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$23.9 M
FY, 2019
CreditSafe Score
?
Score changed on Oct 09, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 283.1M | 63.9M | 35.5M | 52.3M | 89.7M | 109.6M | 138.9M | 75.6M | 23.9M |
| General and administrative expense | 38.7M | 43.7M | 41.1M | 45.2M | 48.1M | 64.5M | 82.2M | 149.8M | |
| Operating expense total | 103.4M | 124.0M | 145.1M | 151.6M | 174.1M | 184.3M | 231.4M | 209.1M | 335.6M |
| EBIT | 179.7M | (60.1M) | (109.6M) | (99.4M) | (84.4M) | (74.7M) | (92.6M) | (181.3M) | (298.1M) |
| EBIT margin, % | 63.5% | -94.0% | -309.0% | -190.2% | -94.2% | -68.2% | -66.6% | -239.9% | -1248.9% |
| Interest income | 746.0K | 1.2M | 950.0K | 548.0K | 808.0K | 2.2M | 4.4M | 6.2M | 9.2M |
| Interest expense | 91.0K | 1.5M | 1.2M | 796.0K | 1.1M | 53.7M | 4.5M | 5.3M | 8.0M |
| Net Income | 180.4M | (58.6M) | (108.4M) | (98.6M) | (83.3M) | (21.0M) | (88.1M) | (176.1M) | (290.1M) |